Liz Galle's most recent trade in CVRx Inc was a trade of 26,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 18, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CVRx Inc | Liz Galle | VP OF GLOBAL CLINICAL RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 26,000 | 26,000 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Liz Galle | VP OF GLOBAL CLINICAL RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Liz Galle | VP of Global Clinical Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 25,900 | 25,900 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Liz Galle | VP of Global Clinical Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 19,700 | 19,700 | - | - | Stock Option (right to buy) |